Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination

Vaccine

Volumn 19, Issue 31, 2001, Pages 4511-4518

  Orciari, Lillian A ^a,b   Niezgoda, Michael ^a   Hanlon, Cathleen A ^a   Shaddock, John H ^a   Sanderlin, Dane W ^a   Yager, Pamela A ^a   Rupprecht, Charles E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Oral vaccination; Pathogenesis; Rabies virus

Indexed keywords

RABIES VACCINE; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN; VIRUS NUCLEOPROTEIN; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CHEEK MUCOSA; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG SAFETY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RABIES; RABIES VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TONGUE; TONSIL; TREATMENT OUTCOME; VACCINATION; VIRUS ATTENUATION; VIRUS DETECTION; VIRUS GENE; VIRUS IMMUNITY; VIRUS ISOLATION; VIRUS REPLICATION;

ADMINISTRATION, ORAL; ANIMALS; DOG DISEASES; DOGS; MICE; RABIES; RABIES VACCINES; RABIES VIRUS; VACCINATION; VACCINES, ATTENUATED;

EID: 0035859988     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00186-4     Document Type: Article

References (46)

1. Rationale and prospects for rabies elimination in developing countries
2. Results of an oral rabies vaccination program for coyotes
3. Oral immunization of wildlife
4. Prevention of the spread of rabies to wildlife by oral vaccination of raccoons in Massachusetts
5. Oral rabies vaccination field trials in Europe, with recent emphasis on France
6. Vaccination against rabies: Construction and characterization of SAG2, a double derivative of SAD Bern
7. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus
8. Rabies virulence: Effect on pathogencity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein
9. SAG2 oral rabies vaccine
10. Oral rabies vaccination of dogs
11. Evaluation of the safety of two attenuated oral rabies vaccines, SAG1 and SAG2, in six arctic mammals
12. Safety study of the SAG2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in France
13. Comparison of the efficacy of the antirabies vaccines used for foxes in France
14. Innocuity studies of SAG2 oral rabies vaccine in various Zimbabwean wild non-target species
15. Immunogencity, efficacy and safety of oral rabies vaccine (SAG2) in dogs
16. Pathogenesis of experimentally induced rabies in domestic ferrets
17. Immunohistochemical test for rabies: Identification of a diagnostically superior monoclonal antibody
18. Use of a single anti-nucleocapsid monoclonal antibody to detect rabies antigen in formalin-fixed paraffin-embedded tissues
19. The fluorescent antibody test
20. Surveillance and epidemiologic mapping of monoclonal antibody defined rabies variants in Florida
21. Point mutation analysis in a mamalian gene: Rapid preparation of total RNA, PCR amplifcation of cDNA, and Taq sequencing by a novel method
22. Unexplained rabies in three immigrants in the United States
23. Epidemiologic and historical relationships among 87 rabies virus isolates as determined by limited sequence analysis
24. Typing rabies virus isolates by DNA enzyme immunoassay
25. A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus neutralizing antibody
26. A comparison of two serological methods for detecting the immune response after rabies vaccination in dogs and cats being exported to rabies-free areas
27. The infectivity and pathogenesis of rabiesvirus administered orally
28. Oral vaccination of foxes against rabies
29. The use of commercially available vaccines for the oral vaccination of foxes against rabies
30. Further studies of sylvatic rabies in the silver fox (Vulpes vulpes)
31. Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores
32. Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor)
33. Determination of the site of oral rabies vaccination
34. Common mucosal immune system and strategies for the development of vaccines effective at the mucosal surfaces
35. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus
36. Differences in cell to cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro
37. Rabies virus infection: Genetic mutations and the impact on viral pathogenicity and immunity
38. Amplification of rabies virus stimulation of human T-cell lymphocytes by antigen-specific antibodies
39. Immunobiology of lyssaviruses: The basis for immunoprotection
40. Mucosal immunity to viruses
41. Safety evaluation of the SAG2 rabies virus mutant in Tunisian dogs and several non-target species
42. Rabies pathogenesis in SCID mice: Street virus and an avirulent mutant